Model Integration and Configuration for Market Access

Data Characteristics for This Category

Market access clinical trial pre-screening primarily uses data from global clinical trial registries (e.g., ClinicalTrials.gov, EU Clinical Trials Register), regulatory agency approval documents (FDA, EMA), academic publications, conference abstracts, and pharmaceutical companies' public annual reports. Data updates frequently. Clinical trial registry data typically updates weekly or monthly. Approval documents follow the release schedules of national regulatory agencies. Document structures vary. They include structured database records, unstructured PDF documents (e.g., study protocols, ethics approvals, product labels), and semi-structured web pages. Key fields include trial phase, indication, drug target, sponsor, research center, subject inclusion/exclusion criteria, primary/secondary endpoints, biomarkers, approval status, and market launch country and date. Units for dosage are commonly milligrams (mg) and micrograms (µg). Time units are days, weeks, months, and years. Subject counts are integers.

Constraints Imposed by These Characteristics on Model Integration and Configuration

The wide range of data sources and diverse structures require robust multi-source heterogeneous data processing capabilities for model integration, especially for unstructured document parsing. High update frequency necessitates incremental update mechanisms for model training and knowledge base synchronization to ensure timely pre-screening results. Complex medical terminology, abbreviations, and multi-language descriptions in documents challenge the model's semantic understanding. This requires configuring specialized medical vocabularies or domain-specific pre-trained models. Accurate extraction of core fields is fundamental for pre-screening accuracy. Therefore, the model needs targeted optimization for entity recognition and relationship extraction. For example, subject inclusion/exclusion criteria are often free text with complex logical structures, requiring the model to accurately parse nested conditions. Furthermore, critical information like approval status and market launch time directly impacts market access decisions. The model must accurately link and extract this information from different documents.

Configuration Settings

Configuration Item	Suggested Value	Rationale
`Chunk size` (Segment Length)	`800–1200 characters`	Clinical trial documents have long paragraphs; ensures complete context.
`Chunk Overlap Length` (Overlap Length)	`150–200 characters`	Prevents fragmentation of medical terms and logical relationships across segments.
`Similarity threshold` (Similarity Threshold)	`0.75–0.85`	Ensures high relevance of recalled results to query intent, reducing noise.
`Recall count` (Recall Count)	`Top 10–15 items`	Covers potentially relevant information, balancing recall and processing efficiency.
`Rerank result count` (Reranked Return Count)	`Top 5 items`	Focuses on the most relevant key information, improving final output precision.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Handles parsing large PDF documents, preventing timeouts.

Three Common Pitfalls

Model tests show connector error. This typically results from incorrect model service address configuration or network connectivity issues. An example is http://localhost:11434 being blocked by a firewall.
Model tests succeed, but responses are empty or incomplete during conversation. This may occur if the model's return data format does not match FastGPT's expected format, or if the model's generated content is truncated due to excessive length.
Processing certain clinical trial documents results in a Failed to parse document: "Invalid PDF structure" error. This indicates the document parser cannot recognize the specific PDF format. The parser may need updating, or an alternative parsing library might be required.

How to Verify Configuration

Upload multiple documents from different sources (e.g., ClinicalTrials.gov registration information, FDA approval PDF files). Check if knowledge base segmentation and vectorization are successful. Verify that Chunk size (Segment Length) and Chunk Overlap Length (Overlap Length) meet expectations.
For a specific indication or target, input queries containing complex medical terms. Observe the Similarity scores of the model's recalled results. Manually verify if Recall count (Recall Count) and Rerank result count (Reranked Return Count) include key information.
Simulate a real pre-screening scenario. Ask questions about market access conditions for a specific drug in a particular country. Check if the model accurately extracts and integrates core field information, such as approval status and market launch time, from the knowledge base.

Note: The values provided are common starting points. They should be measured against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.